ADC Therapeutics (ADCT) Earnings Date, Estimates & Call Transcripts $1.28 -0.14 (-9.51%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$1.28 0.00 (0.00%) As of 05/6/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADC Therapeutics Earnings Summary Latest Q4 Earnings DateMar. 27EstimatedConsensus EPS (Mar. 27) -$0.35 Actual EPS (Mar. 27) -$0.29 Beat By $0.06 Actual Revenue (Mar. 27) $19.00MADC Therapeutics posted Q4 2024 earnings on March 27, 2025, reporting an EPS of -$0.29, which beat the consensus estimate of -$0.35 by $0.06. Quarterly revenue was reported to be $19 million, below the consensus estimate of $19.01 million. With a trailing EPS of -$1.65, ADC Therapeutics' earnings are expected to grow next year, from ($1.69) to ($1.52) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Annual Report (10-K)Slide DeckFull Screen Slide DeckPowered by Get ADC Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ADC Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataADCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADCT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ADC Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.39-$0.29-$0.34Q2 20252-$0.40-$0.31-$0.36Q3 20252-$0.41-$0.35-$0.38Q4 20252-$0.42-$0.36-$0.39 ADC Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/27/2025Q4 2024-$0.35-$0.29+$0.06-$0.29$19.01M$19.00M11/7/2024Q3 2024-$0.36-$0.42 -$0.06-$0.42$18.76M$18.46M8/6/2024Q2 2024-$0.44-$0.38+$0.06-$0.38$19.06M$17.41M5/6/2024Q1 2024-$0.56-$0.56--$0.56$18.19M$18.05M3/13/2024Q4 2023-$0.47-$1.03 -$0.56-$1.03$16.58M$16.79M11/7/2023Q3 2023-$0.61-$0.58+$0.03-$0.58$14.57M$14.49M8/8/2023Q2 2023-$0.44-$0.58 -$0.14-$0.58$34.77M$19.28M5/9/2023Q1 2023-$0.80-$0.74+$0.06-$0.74$20.10M$18.99M ADC Therapeutics Earnings - Frequently Asked Questions When did ADC Therapeutics announce their last quarterly earnings? ADC Therapeutics (NYSE:ADCT) last announced its quarterly earning data on Thursday, March 27, 2025. Learn more on ADCT's earnings history. Did ADC Therapeutics beat their earnings estimates last quarter? In the previous quarter, ADC Therapeutics (NYSE:ADCT) reported ($0.29) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.35) by $0.06. Learn more on analysts' earnings estimate vs. ADCT's actual earnings. How can I listen to ADC Therapeutics's earnings conference call? The conference call for ADC Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read ADC Therapeutics's conference call transcript? The conference call transcript for ADC Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does ADC Therapeutics generate each year? ADC Therapeutics (NYSE:ADCT) has a recorded annual revenue of $70.84 million. How much profit does ADC Therapeutics generate each year? ADC Therapeutics (NYSE:ADCT) has a recorded net income of -$240.05 million. ADCT has generated -$1.65 earnings per share over the last four quarters. What is ADC Therapeutics's EPS forecast for next year? ADC Therapeutics's earnings are expected to grow from ($1.69) per share to ($1.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies KROS Earnings Results AKBA Earnings Results COGT Earnings Results RLAY Earnings Results VALN Earnings Results TYRA Earnings Results SION Earnings Results KURA Earnings Results PRTA Earnings Results URGN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NYSE:ADCT) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADC Therapeutics SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ADC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADCT Stock Free ADCT Stock Alerts